Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hypothetical protein, conserved | 0.3139 | 0 | 0.5 |
Echinococcus granulosus | alpha 16 mannosyl glycoprotein | 2.1052 | 1 | 0.5 |
Schistosoma mansoni | beta-12-n-acetylglucosaminyltransferase II | 2.1052 | 1 | 0.5 |
Echinococcus multilocularis | alpha 1,6 mannosyl glycoprotein | 2.1052 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.3139 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.3139 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 2.1052 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | < 30 % | Inhibition of rat intestine sucrase using sucrose as substrate at 10 mg/ml incubated for 10 mins prior to substrate addition measured after 40 mins by glucose oxidase colorimetric method | ChEMBL. | 23811091 |
Inhibition (binding) | < 30 % | Inhibition of rat intestine maltase using maltose as substrate at 10 mg/ml incubated for 10 mins prior to substrate addition measured after 40 mins by glucose oxidase colorimetric method | ChEMBL. | 23811091 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.